InspireMD announces issuance of key U.S. patent covering SwitchGuard NPS

InspireMD announced the issuance of U.S. Patent No. 11,844,893, titled, “Shunts with Blood Flow Indicators.” The patent covers key aspects of the company’s SwitchGuard Neuroprotection System, NPS, along with future features in development that are expected to enable the treating physician to visualize flow through the system. The SwitchGuard NPS is designed to allow the physician to reverse blood flow to the brain during a carotid artery stenting procedure, including Transcarotid Artery Revascularization or other neurovascular procedures. The SwitchGuard NPS is designed to prevent embolic debris generated during the procedure from traveling to the brain. Marvin Slosman, Chief Executive Officer of InspireMD, stated, “The issuance of this patent demonstrates our continued priority to develop and build on our robust intellectual property to support our innovations, while expanding our product portfolio for optimal patient outcomes in the treatment of carotid artery disease with the utmost safety in mind. This coupled with our CGuard Prime Carotid Stent System should provide clinicians with innovation and safety during carotid revascularization procedures and minimize the risk of stroke.”